PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.

TitlePET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.
Publication TypeJournal Article
Year of Publication2016
AuthorsLee SYee, T Kingham P, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD
JournalHPB (Oxford)
Volume18
Issue1
Pagination41-8
Date Published2016 Jan
ISSN1477-2574
KeywordsAdenoma, Liver Cell, Adult, Biomarkers, Tumor, Biopsy, Databases, Factual, Diagnostic Errors, DNA Mutational Analysis, False Positive Reactions, Female, Fluorodeoxyglucose F18, Hepatocyte Nuclear Factor 1-alpha, Humans, Incidental Findings, Liver Neoplasms, Male, Mutation, Positron-Emission Tomography, Predictive Value of Tests, Radiopharmaceuticals, Reproducibility of Results, Retrospective Studies, Tomography, X-Ray Computed
Abstract

BACKGROUND: Hepatocellular adenoma (HCA) is the second most common benign liver neoplasm and occurs predominantly in women in their reproductive years. Positron emission tomography (PET) using [18F] fluorodeoxyglucose (FDG) is commonly used in cancer staging, surveillance and evaluation of treatment response. PET-avid HCA are rare and can be falsely interpreted as malignancies.

METHODS: A retrospective review of four institutions' database was performed to identify the PET-avid HCAs with clinico-pathological correlation.

RESULTS: Nine patients with histological proven PET-avid HCA was identified. Eight out of 9 patients were female with a median age at diagnosis of 44 years. All patients' tumors with available histological subtyping (8/8) were HNF1-α mutated and had no inflammatory changes; 6 out the 9 lesions had prominent (>50%) steatotic changes.

CONCLUSION: Hepatocellular adenomas, specifically the HNF1-α subtype, can cause false-positive PET findings when seeking to identify malignancy. Concomitantly, PET-CT may have the potential to identify the HCA histopathologic variant with the lowest malignant and hemorrhagic potential.

DOI10.1016/j.hpb.2015.07.001
Alternate JournalHPB (Oxford)
PubMed ID26776850
PubMed Central IDPMC4750225
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States
Related Faculty: 
Jose Jessurun, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700